Monopar Therapeutics Inc. (MNPR)
NASDAQ: MNPR · Real-Time Price · USD
19.00
-0.01 (-0.05%)
At close: Nov 20, 2024, 4:00 PM
17.99
-1.01 (-5.32%)
Pre-market: Nov 21, 2024, 4:41 AM EST
Monopar Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Nov '24 Nov 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 100 | 5 | 31 | 40 | 70 | 173 | |
| Market Cap Growth | 170.35% | -83.48% | -24.23% | -42.33% | -59.48% | - | |
| Enterprise Value | 94 | -3 | 16 | 18 | 52 | 169 | |
| Last Close Price | 19.00 | 1.70 | 11.85 | 16.05 | 30.60 | 83.00 | |
| PB Ratio | 13.54 | 0.91 | 3.03 | 2.13 | 4.47 | 13.70 | |
| P/TBV Ratio | 4.80 | 0.91 | 3.03 | 2.13 | 4.47 | 13.70 | |
| Debt / Equity Ratio | - | - | 0.00 | - | - | - | |
| Quick Ratio | 5.36 | 4.13 | 4.19 | 12.85 | 14.22 | 18.25 | |
| Current Ratio | 5.41 | 4.17 | 4.21 | 12.98 | 14.28 | 18.27 | |
| Return on Equity (ROE) | -112.04% | -107.19% | -72.44% | -52.57% | -44.52% | -43.23% | |
| Return on Assets (ROA) | -59.67% | -53.66% | -39.03% | -30.51% | -26.92% | -26.15% | |
| Return on Capital (ROIC) | -75.69% | -70.38% | -45.36% | -32.94% | -28.73% | -27.65% | |
| Earnings Yield | -6.46% | -166.13% | -34.34% | -22.52% | -9.00% | -2.44% | |
| FCF Yield | -5.94% | -155.38% | -23.61% | -18.11% | -6.65% | -1.74% | |
| Buyback Yield / Dilution | -23.15% | -8.69% | -1.97% | -13.82% | -17.56% | -0.32% | |
| Total Shareholder Return | -23.15% | -8.69% | -1.97% | -13.82% | -17.56% | -0.32% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.